CC
ORIC icon

Corton Capital’s Oric Pharmaceuticals ORIC Stock Holding History

Corton Capital’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,440
Closed -$179K – 575
2024
Q3 		$179K Sell
17,440
-19,203
-52% -$190K 0.09% 401
2024
Q2 		$259K Buy
+36,643
New +$328K 0.14% 242
2022
Q2 		– Sell
-10,501
Closed -$56K – 465
2022
Q1 		$56K Sell
10,501
-6,411
-38% -$57.7K 0.02% 411
2021
Q4 		$249K Buy
+16,912
New +$264K 0.11% 189

Other funds holding ORIC

P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corton Capital's ORIC Position: Q4 2024 in Review

Corton Capital sold out of Oric Pharmaceuticals (ORIC) in Q4 2024, closing a stake of 17,440 shares — an estimated $179K sold.

Corton Capital first reported a position in ORIC in Q4 2021 and held it in 4 quarters. The position peaked at $259K in Q2 2024. 129 funds tracked by Wall St. Rank hold ORIC as of Q4 2024.

  • Corton Capital reported no remaining Oric Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 17,440 Oric Pharmaceuticals shares in Q4 2024, an estimated $179K.
  • Corton Capital first reported a position in Oric Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Corton Capital's Oric Pharmaceuticals position peaked at $259K in Q2 2024.
  • 129 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.